Literature DB >> 27425160

Nephrotic syndrome: PCSK9: a target for hypercholesterolaemia in nephrotic syndrome.

Alan W J Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27425160     DOI： 10.1038/nrneph.2016.111

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.

Authors:  Mary E Haas; Amy E Levenson; Xiaowei Sun; Wan-Hui Liao; Joseph M Rutkowski; Sarah D de Ferranti; Valerie A Schumacher; Philipp E Scherer; David J Salant; Sudha B Biddinger
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690
  1 in total
  4 in total

Review 1.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

2.  Chronic Systemic Toxicity Study of Copper Intrauterine Devices in Female Wistar Rats.

Authors:  Xia Zhao; Qian Liu; Haixiang Sun; Yali Hu; Zhaoxu Wang
Journal:  Med Sci Monit       Date:  2017-08-16

3.  Vaccine Against PCSK9 Improved Renal Fibrosis by Regulating Fatty Acid β-Oxidation.

Authors:  Danyu Wu; Yanzhao Zhou; Yajie Pan; Chang Li; Yingxuan Wang; Fen Chen; Xiao Chen; Shijun Yang; Zihua Zhou; Yuhua Liao; Zhihua Qiu
Journal:  J Am Heart Assoc       Date:  2019-12-24       Impact factor: 5.501

4.  Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome.

Authors:  Claire Bryant; Galen Rask; Amanda P Waller; Amy Webb; Marina R Galdino-Pitta; Angelica A Amato; Rachel Cianciolo; Rajgopal Govindarajan; Brian Becknell; Bryce A Kerlin; Francisco A R Neves; Alessia Fornoni; Shipra Agrawal
Journal:  iScience       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.